Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib

This case series measured the results of using upadacitinib for moderate or severe cases of epidermolysis bullosa pruriginosa.

Authors

Zeqiao Zhang (ORCID: https://orcid.org/0000-0003-0333-9512)
Zhimiao Lin (ORCID: https://orcid.org/0000-0001-9323-2035)

Institutions

Southern Medical University (CN)

Publication Details

Journal: JAMA Dermatology
Published: 2024-08-21
DOI: https://doi.org/10.1001/jamadermatol.2024.2787
Citations: 4
Primary Topic: Autoimmune Bullous Skin Diseases
Type: article
Field-Weighted Citation Impact: 1.70

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib

Zeqiao Zhang, Zhimiao Lin

Aug 21, 2024

4 citations

JAMA Dermatology

Autoimmune Bullous Skin Diseases

1.70

article

Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib

Zeqiao Zhang, Zhimiao Lin

August 21, 2024article en

4 citations

Abstract

This case series measured the results of using upadacitinib for moderate or severe cases of epidermolysis bullosa pruriginosa.

JAMA DermatologyVol. 160(10)

Southern Medical University (CN)

Openalex Percentile: Top 16%

Autoimmune Bullous Skin Diseases

1.70

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Epidermolysis Bullosa Pruriginosa Treated With Upadacitinib — Zeqiao Zhang, Zhimiao Lin · JAMA Dermatology (2024) | TGRS Research Map | TGRS